Cytoplasmic activation/proliferation-associated protein-1 (Caprin-1), whose expression is significantly elevated in both ESCA tumor tissues and cell lines, is associated with poor prognosis in ESCA patients. This evidence concerns the gene CAPRIN1 and neoplasm.